Patients with incurable cancers should have an easier time getting into clinical trials under new FDA guidance on developing criteria for trial eligibility.
The final guidance marks the latest effort by the Food and Drug Administration to expand the criteria for who can participate in cancer studies. Enrollment has remained an ongoing challenge in oncology research and drug development—a problem that’s only exacerbated by health disparities.
“Particularly for patients with advanced cancers, clinical trials present an important opportunity to receive potentially groundbreaking treatments and optimized care,” Jeff Allen, president and CEO of Friends of Cancer Research, said.
“This latest guidance ...